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Abstract A series of titanium (Ti) based glasses were
formulated (0.62 SiO2–0.14 Na2O–0.24 CaO, with 0.05
mol% TiO2 substitutions for SiO2) to develop glass/cera-
mic scaffolds for bone augmentation. Glasses were initially
characterised using X-ray diffraction (XRD) and particle
size analysis, where the starting materials were amorphous
with 4.5 lm particles. Hot stage microscopy and high
temperature XRD were used to determine the sintering
temperature (*700 C) and any crystalline phases present
in this region (Na2Ca3Si6O16, combeite and quartz).
Hardness testing revealed that the Ti-free control (ScC—
2.4 GPa) had a significantly lower hardness than the
Ti-containing materials (Sc1 and Sc2 *6.6 GPa). Optical
microscopy determined pore sizes ranging from 544 to
955 lm. X-ray microtomography calculated porosity from
87 to 93 % and surface area measurements ranging from
2.5 to 3.3 SA/mm3. Cytotoxicity testing (using mesen-
chymal stem cells) revealed that all materials encouraged
cell proliferation, particularly the higher Ti-containing
scaffolds over 24–72 h.
1 Introduction
Mesoporous materials have generated considerable interest
in recent years for medical applications, such as controlled
drug delivery and synthesis of novel nanomaterials. This is
due to attractive features such as high surface area, uniform
pore size and high pore volume [1]. Highly porous mate-
rials such as Santa Barbara amorphous type materials
(SBA-15) and mobil crystalline materials (MCM-41) have
been successfully used in drug delivery systems as it is
possible for them to adsorb and release drug molecules
from the meso-structured matrices at a controlled rate,
however, due to the low bioactivity attributed to pure silica,
their use as bone repair substitutes is limited [1]. More
recently focus has turned to using bioactive glasses and
glass–ceramic materials for medical applications, in par-
ticular as bone substitutes and scaffolds. 3D porous scaf-
folds are preferential to using traditional particulates or
granules in treating large bony defects as they provide an
interconnected network which permits hosts cell migration,
nutrient delivery, bone ingrowth and eventually vasculari-
zation [2, 3].
Some specific attributes required for an ideal scaffold, as
suggested by Boccaccini et al. include the ability to deliver
cells to the wound site, excellent osteoconductivity, biode-
gradability, appropriate mechanical strength, high porosity
([90 %) and pore size [400–500 lm. Bioactive glasses
meet a number of these criteria (excellent osteoconductivity
and bioactivity, ability to deliver cells and controllable bio-
degradability) which makes bioactive glasses an attractive
group of materials as scaffolds for tissue engineering [3–5].
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Studies on glass–ceramic scaffolds derived from Hench’s
45S5 Bioglass have shown to exhibit appropriate mechanical
stability, tailorable bioresorbability and excellent bone-
bonding capability due to the formation of a hydroxyapatite
surface layer [1, 3, 5, 6]. Their osteogenic behaviour is
thought to be due to the release of specific concentrations of
ions that stimulates osteogenic cells resulting in bone growth
[5]. Other materials such as apatite-wollastonite bioactive
glass–ceramic (AW–GC) have been investigated due to good
bioactivity, biodegradability and osteoinductivity [7], and
also polylactic acid/calcium phosphate glass scaffolds,
which are completely degradable [8].
The work herein sees the characterisation and develop-
ment of CaO–Na2O–SiO2/TiO2 based glass–ceramic scaf-
folds. Previous work on glasses with similar compositions
determined TiO2 to act as a network modifying cation [9],
and as such, its substitution for SiO2 in this instance may
result in a more biodegradable scaffold. Titanium (Ti) was
used as it has been widely used in the field of orthopaedics
and has exhibited positive tissue response in commercial
biomaterials [10–12]. Ti has been used for developing
craniofacial prosthetics, and ossicular implants [11].
Ti6Al4V implants, Ti–N coatings, K2O–SiO2–TiO2 glasses
and Ti-gels have all reported the growth of a CaP surface
layer when tested in simulated body fluid (SBF) [13–16],
which is reportedly due to a naturally occurring oxide
surface layer which forms Ti–OH-, which in turn, favours
precipitation of Ca and P ions when tested in SBF [13, 16,
17].
This study investigates the substitution of TiO2 for SiO2
in the glass phase of the starting materials and its effect on
the structural, mechanical and biological properties. Scaf-
folds were produced by an existing polymer-sponge method
[4], however, a heat treatment profile for the starting glasses
was derived using both hot stage microscopy (HSM) and
high temperature X-ray diffraction (HT-XRD).
2 Materials and methods
2.1 Material fabrication
2.1.1 Glass melting
Three glass compositions were formulated for this study. The
SiO2 content of the glass was substituted by TiO2 throughout
the series, Sc1 and Sc2 (Table 1). A Ti-free glass was used as
a control (ScC) for comparison. Glasses were prepared by
weighing out appropriate amounts of analytical grade
reagents (Fisher Scientific, Pittsburg PA, USA) and ball
milling (1 h). The powdered mixes were oven dried (100 C,
1 h) and fired (1,500 C, 1 h) in platinum crucibles and
shock quenched in water. The resulting frits were dried,
ground and sieved to retrieve glass powders with a particle
size less than 25 lm.
2.1.2 Glass scaffold production
Scaffolds were produced with each glass formulation deno-
ted ScC, Sc1 and Sc2, where Sc2 contains the highest con-
centration of TiO2. Polyvinyl alcohol (PVA, 0.008 g) was
initially dissolved in 9.3 ml of de-ionised water for 1 h and
heated to 55 C. 12 g of glass powder was added to each flask
and stirred for 1 h. 10 mm 9 8 mm/ cylindrical polyure-
thane foams were cut and immersed in the glass slurry,
stirred with a spatula to ensure all pores were filled within the
slurry. After approximately 10 min the glass embedded
foam was allowed dry on a foam bed for 24 h. The scaffolds
were then heat treated in a furnace to remove the foam and
sinter the suspended glass particles. Figure 1 shows a sche-
matic of the foam production process and subsequent testing
of the scaffolds.
2.1.3 Heat treatment profile
Heat treatment of the glass/ceramic scaffolds was deter-
mined using HSM and HT-XRD. The temperature profile
consists of heating the scaffolds at a rate of 10 C/min to
the sintering temperature and holding for 5 h. The scaffolds
were then heated to the sintering temperature ?40 C at a
rate of 1 C/min and then held for 5 h. The scaffolds were
then cooled slowly to room temperature at a rate of 5 C/min
(Fig. 2).
2.2 Glass characterisation
2.2.1 XRD
Diffraction patterns were collected using a Siemens D5000
X-ray Diffraction Unit (Bruker AXS Inc., WI, USA). Glass
powder samples were packed into standard stainless steel
sample holders. A generator voltage of 40 kV and a tube
current of 30 mA was employed. Diffractograms were col-
lected in the range 10\ 2h\ 80, at a scan step size 0.02
and a step time of 10 s. Any crystalline phases present were
identified using Joint Committee for Powder Diffraction
Studies (JCPDS) standard diffraction patterns.
Table 1 Glass formulations (mol. Fr.)
ScC Sc1 Sc2
SiO2 0.62 0.57 0.52
TiO2 0.00 0.05 0.10
Na2O 0.14 0.14 0.14
CaO 0.24 0.24 0.24
2882 J Mater Sci: Mater Med (2012) 23:2881–2891
123
2.2.2 Network connectivity
The network connectivity (NC) of the glasses was calcu-
lated with Eq. 1 using the molar compositions of the glass.
NC calculations were performed assuming that Ti performs
as a network former and also as a network modifier.
NC ¼ No:BOs  No:NBOs
Total No: Bridging Species
ð1Þ
where NC network connectivity, BO bridging oxygens and
NBO non-bridging oxygens.
2.2.3 Differential thermal analysis (DTA)
A combined differential thermal analyer/differential ther-
mal calorimeter (DSC, Q10-DSC, TA Instrumental Inc.,
New Castle, DE) was used to measure the glass transition
temperature (Tg) for each glass. A heating rate of 20 C/
min was used in a nitrogen atmosphere up to a maximum
temperature of 700 C, using a blank reference in a mat-
ched platinum crucible.
2.2.4 Particle size analysis (PSA)
Particle size analysis (PSA) was achieved using a Beckman
Coulter Multisizer 4 Particle size analyser (Beckman-
Coulter, Fullerton, C.A, USA). The glass powder samples
were evaluated in the range of 0.4–100.0 lm and the run
length took 60 s. The fluid used was water and was used at
a temperature range between 10 and 37 C. The relevant
volume statistics were calculated on each glass.
2.2.5 HSM
A MISURA side view hot stage microscope (HSM), Expert
Systems (Modena, Italy), with image analysis system and
electrical furnace, with max temperature of 1,600 C and
max rate of 80 C/min. The parameters for this experiment
Fig. 1 Flow chart for scaffold
fabrication and testing
Fig. 2 Sintering profile used for scaffolds
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were a heat rate of 20 C/min from 20 to 500 C and 5 C/
min from 500 to 1,200 C. The computerised image anal-
ysis system automatically records and analyses the sample
geometry during heating.
2.2.6 HT-XRD
Powders were analysed using a custom high temperature
XRD furnace using a Siemens D5000 XRD unit with a
Vantec1 linear position-sensitive detector [18]. Cu Ka
radiation was used, and measurements were collected over
an angular range of 10–70 2h with scan rate of 2.25/min.
Patterns were measured at RT and from 400 to 800 C in
steps of 20 C. Samples were heated at a rate of 20 C/min
and then cooled at 60 C/min. All measurements were
performed in static air.
2.3 Hardness testing
Hardness testing was completed on discs (8/ 9 2 mm)
sintered using the same heat treatment profile as the scaf-
folds, where 10 measurements were taken on each disc and
three discs were used for each material (total n = 30/
sample). A Shimadzu HMV-2000 hardness testing machine
was used with a 500 g load cell with 15 s intervals.
2.4 Scaffold analysis
2.4.1 Scanning electron microscopy and energy dispersive
X-ray analysis (SEM–EDS)
Backscattered electron (BSE) imaging was carried out with
an FEI Co. Quanta 200F Environmental Scanning Electron
Microscope. Additional compositional analysis was per-
formed with an EDAX Genesis Energy-Dispersive Spec-
trometer (EDS). All EDS spectra was collected at 20 kV
using a beam current of 26 nA. Quantitative EDS spectra
was subsequently converted into relative concentration
data.
2.4.2 Optical microscopy
Estimation of pore size was conducted using an Olympus
IX20-UCB Optical Fluorescent Microscope at 49 magni-
fication. Mean pore size was calculated by measuring the
diameter of (1) starting polyurethane scaffolds, (2) ScC, (3)
Sc-1 and (4) Sc-2. 10 pores were measured from three dif-
ferent scaffolds (total n = 30) for each material and the
mean and standard deviation was calculated. The software
used to measure the pore size was Image-Pro AMS 5.1
where a 100 lm calibration standard was used for accuracy.
2.4.3 X-ray microtomography
The porous scaffold samples were examined using a
Phoenix NanotomTM X-ray microtomography system (GE
Sensing and Inspecting Technologies, Boston, USA). The
X-ray source was molybdenum, to which a current of
160 lA Amps and a voltage of 70 kV was applied. 360
radiographs were collected through a rotation of 0–360
without the use of filters. Radiographs were collected using
a 2 megapixel high contrast flat panel digital detector with
three frame averages per acquired radiograph, skipping the
first acquisition (to prevent vibration). Volumetric recon-
struction was carried out using datosIX—reconstruction
software (GE Sensing and Inspecting Technologies). Dur-
ing the image reconstruction process, the beam hardening
correction parameter was set to 50 %. The porosity and
surface area were calculated and analysed using Volume
graphics studioTM software by extracting a volumetric
region of interest (ROI) and analysing that volume for %
filled space and total surface area. From this information,
porosity (%) and surface area/mm3 was determined.
2.5 Stem-cell culture analysis
Murine mesenchymal stem cells from transgenic DsRed
mice which constitutively express a red fluorescent protein
[19] were obtained as previously described [20]. Cells were
cultured in Mesencult basal medium, supplemented with
10 % (v/v) Mesencult supplement (Stem Cell Technolo-
gies, Vancouver, Canada) and used at low passage (\10)
[20]. MSC expressed CD90 and CD105 but not CD34,
CD45 or MHC class II, and possessed tri-lineage differ-
entiation potential [21]. Procedures were approved by the
research ethics committee of the National University of
Ireland, Maynooth. Scaffolds were sterilized by autoclav-
ing at 120 C for 20 min and stored overnight in complete
culture medium. All activities were performed aseptically
and all incubations performed at 37 C in a humidified 5 %
CO2 atmosphere. Scaffolds were washed twice in sterile
PBS, and placed in sterile polystyrene Petri dishes (Nal-
geNunc International, Rochester, NY). To each scaffold,
200 ll of MSC at 2 9 105 cells/ml were carefully dis-
tributed, allowing all of the seeding culture to enter the
scaffold; this was cultured for 2 h to allow MSC adherence.
At the end of this period, scaffolds to which MSC had
adhered, were removed and cultured in 1 ml of fresh cul-
ture medium in 24 well tissue culture plates (NalgeNunc
International), such that scaffolds were completely sub-
merged. Scaffolds were examined by epi-fluorescent
microscopy. MSC proliferation was determined by WST-1
assay (Roche Diagnostics, Indianapolis, USA) according to
the manufacturer’s instructions.
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2.6 Statistical analysis
One-way analysis of variance (ANOVA) was employed to
compare means where applicable. Comparison of relevant
means was performed using the post hoc Bonferroni test.
Differences between groups was deemed significant when
P B 0.05. Statistical analysis was performed using SPSS
software for windows version 16 (SPSS Inc. Chicago, IL).
3 Results and discussion
The starting materials developed for this study were CaO–
Na2O–SiO2 based glasses (ScC) and the Ti substituted
experimental glasses, Sc1 and Sc2. Initially XRD was
undertaken to ensure that each starting material was
amorphous prior to heat treatment (Fig. 3a). PSA was also
conducted in order to determine the mean particle size and
distribution post-grinding and sieving. Figure 3b shows
that there is no significant change in particle size between
materials and the size ranged from 4.65 lm (ScC), 4.61 lm
(Sc1) to 4.36 lm (Sc2). Smaller particle sizes are prefer-
ential for sintering and particle sizes of \5 lm have pre-
viously been used for fabrication of Bioglass based
scaffolds [22].
Network connectivity (NC) calculations were carried
out to theoretically determine the structural role played by
TiO2 as it substitutes SiO2 in the glass network. Assuming
TiO2 performs as a network modifier, the NC decreases
from 2.77 (ScC) to 2.49 (Sc1) to 2.15 (Sc2). Thermal
analysis of each glass revealed no significant change in
glass transition temperature (Tg) between ScC (606 C) and
Sc1 (611 C), however, Sc2 reduced slightly to 596 C.
This slight reduction in Tg may be attributed to de-poly-
merisation of Si–O–Si glass network as indicated by the
reduction in NC as has been previously determined by the
authors [9]. It may also be the case that the relatively low
substitution of TiO2 for SiO2 results in a relatively insig-
nificant change in Tg (Fig. 4).
To determine the sintering temperature of each glass,
HSM was employed. HSM determined that the sintering
temperature of each material was similar considering the
control ScC—695 C, Sc1—707 C and Sc2—695 C. The
addition of TiO2 was also found to reduce the melt temper-
ature (Sc1, Sc2—1,107 C) when compared to the control
(ScC—1,146 C) which is also indicative of a de-polymer-
ised silicate glass network. In order to determine any
mechanical differences attributed to TiO2, hardness testing
was performed on sintered discs produced from each glass,
ScC, Sc1 and Sc2. Results determined ScC to have a much
lower hardness value than either of the Ti containing sam-
ples. ScC hardness was found to be 2.4 GPa which was
significantly lower than both Sc1 (7.1 GPa, P = 0.0001) and
Sc2 (6.1 GPa, P = 0.0001), suggesting that the inclusion of
TiO2 results in a more interconnected glass/ceramic structure
post-sintering. At present porous scaffolds are suitable as
grafts for low-load sites subjected to compression only, such
as fused spinal vertebrae [23]. In this case the mechanical
strength of the materials can be achieved during processing
by altering the starting composition (Fig. 5).
Fig. 3 a XRD scans of initial glass series, b particle size of glass series
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A possible explanation for the different mechanical
properties when comparing the Ti scaffolds to the Ti-free
scaffolds, may be the reduction in Si–O–Si bonds in the
Ti-containing materials. As these bonds decrease with the
addition of network modifiers, the concentration of non-
bridging oxygens (NBOs) increases. This would likely
facilitate greater interconnectivity during heat treatment as
less thermal energy would be required to decompose the
glass structure.
High temperature XRD (HT-XRD) was undertaken to
determine the degree of crystallization occurring at the
sintering temperature during processing, and also to
determine crystal phases present. HT-XRD phase
identification revealed Na2Ca3Si6O16, combeite (Na6Ca3-
Si6O18) and quartz (SiO2) phases which were present in
each material after cooling. XRD was performed on the
ground up scaffolds post-sintering and it was found that at
the sintering temperature (700–760 C), crystal formation
was also present. This was particularly evident in the
control material (ScC), however, crystal formation was also
present in the Ti-containing materials (Sc1 and Sc2), but to
a lesser degree. It was observed that as the concentration of
TiO2 increased, the degree of crystallinity was found to
reduce to the point where Sc2 partially retained some of its
amorphous character, suggesting Ti possible role in
inhibiting crystallization. The crystal phases present in the
Fig. 4 a Network connectivity
and b Tg of glass series
Fig. 5 a Hot stage microscopy
and b hardness testing of glass
series
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ground up scaffolds were found to be predominantly
sodium–calcium–silicate (Na2Ca3Si6O16) (Fig. 6).
High temperature XRD (HT-XRD) revealed that low-
level crystallinity was present at the sintering temperature;
however, the characteristic amorphous trace was also
retained. As was expected, with an increase in temperature
(*820 C), the amorphous content from each material was
partially converted to exhibit crystalline phases. It has been
suggested that the use of porous bioactive glasses as
scaffolding materials is limited by their mechanical prop-
erties and that the sintering profiles employed to enhance
their mechanical properties are performed in a range of
temperatures, particularly between 900 and 1,100 C,
causing the glasses (for example Bioglass) to crystallize
into a glass/ceramic [24]. Although this fact does not
compromise the formation of bone–biomaterial bonding,
the HA formation in vitro as well as the bonding process in
vivo are slowed down by crystallization and the rate of HA
formation decreases as the percentage of crystallization
increases [24]. The low-level of crystallinity presented here
at the sintering temperature is favourable as these materials
will impart greater bioactivity in vivo due to the thera-
peutic effect of the glass phase. High sintering tempera-
tures can result in turning bioactive glasses, such as
Bioglass 45S5, into inert materials [25].
Glass/ceramic scaffolds were produced according to the
temperature profile presented in Fig. 2, and are composed
of both amorphous and crystalline phases. Microscopy,
both SEM and optical microscopy was employed to
investigate the structure of the scaffolds. SEM/EDS was
used initially to clarify the absence of Ti in the control
scaffold (ScC) and to confirm the presence of Ti in Sc1 and
Sc2. It was also determined that Ca, Na, Si and O were also
present for each material. SEM imaging shows the pres-
ence of the porous sintered scaffolds (Fig. 7a), and the
sintered surface of Sc2 showing interlocking of the crystal
grains (Fig. 7b). Rough surfaces, as presented in Fig. 7b,
can be advantageous in scaffold fabrication as a rough
surface is an ideal texture to induce progenitor cell
attachment and adsorption of biological metabolites [24].
Optical microscopy (Fig. 8) was used to determine the
mean pore diameter of the starting foam, and the sintered
glass/ceramic scaffolds (post heat treatment). Measurement
of the polymer foam determined a mean pore diameter of
955 lm. Post-coating and sintering the mean pore diameter
showed an overall decrease, which was particularly evident
with the Ti containing materials. The Ti-free control (ScC)
exhibited a mean pore diameter of 678 lm, while Sc1 and
Sc2 showed a significant reduction in pore diameter when
compared to the pre-processed polymer, 528 lm
(P = 0.000) and 544 lm (P = 0.000), respectively. This is
expected as the polymer burns out, the glass particles
densify during the sintering process resulting in a reduced
pore diameter. The smaller pore diameter as experienced
with Sc1 and Sc2 suggests a higher degree of densification
than the control ScC, however, this difference does not
reach statistical significance. The pore diameter determined
here correlates well to suggestions by Chen et al. that a
pore diameter of[400–500 lm is suitable for scaffolds for
tissue engineering applications [4, 26, 27] and a pore
diameter of at least 100 lm to allow cell migration [26,
28]. It has been reported in the literature that large pores
can be very effective in satisfying cell size and migration
requirements, however, it has also been cited that
micropores (\10 lm) are required to promote fluid diffu-
sion [24] and capillary growth [29].
X-ray microtomography was further employed to ana-
lyse the porous structure of the scaffolds. Figure 9 shows
the X-ray microtomographic images of each scaffold.
Figure 9a represents the control scaffolds ScC, which have
thicker trabecular-like support struts when compared to
Fig. 6 a HT-XRD scan of Sc1 forming Na2Ca3Si6O16, combeite and
quartz phases and b XRD of ground up scaffolds post cooling
exhibiting predominantly forming Na2Ca3Si6O16 phases
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both Sc1 and Sc2. The struts of the experimental scaffolds
(Sc1 and Sc2) become thinner, which may be attributed to
the TiO2 content present in the initial Sc1 and Sc2 glasses.
X-ray microtomography was also used to determine the
porosity and relative surface area of each of the glass/
ceramic scaffolds. Porosity and surface area data is pre-
sented in Fig. 10. Porosity of the ScC was at 87 % which
is lower than both the Ti containing scaffolds at 89 %
(Sc1) and 93 % (Sc2). A high degree of porosity ([90 %)
has been cited in the literature as a preferential attribute
for scaffold fabrication [4, 29, 30] as the porosity of
trabecular bone is cited in the range of 80–90 % [30]. The
porosity of these scaffolds was quantified by surface area
analysis where the ScC produced the highest surface area
(3.3) which corresponds to the lower value determined for
the porosity. Sc1 and Sc2 show a lower surface area of
2.5 and 2.8, respectively, which can also be attributed to
the higher degree of porosity experienced by these
materials.
Structural analysis of the scaffolds determined that a
higher degree of porosity and a smaller pore diameter is
found with the higher Ti-containing scaffold, Sc2. This
may serve as a positive attribute as smaller pores coupled
with higher porosity may facilitate increased proliferation
of cells in vivo.
In order to determine the bioactivity of these materials,
each scaffold was subjected to cytotoxicity testing using
mesenchymal stem cells (MSC) in order to determine cell
viability after 24 and 72 h exposure times. ScC, Sc1 and
Sc2 were each able to support the attachment and pro-
liferation of adult MSCs. To visualise this, a novel
approach was used whereby MSC were derived from a
transgenic mouse expressing a protein such that stem cells
fluoresce intensely under UV illumination. Red MSC are
clearly visible on Sc1 and Sc2 (Fig. 11a, b, respectively).
Microscopy, however, is an inaccurate measure of
Fig. 7 SEM and EDX analysis
of ScC and Sc2 scaffolds
Fig. 8 Optical microscopy of pores from each material
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viability or proliferation as cells may colonise scaffold
surfaces not visible by microscopy. The nature of glass
scaffolds render them unsuitable to tissue sectioning
approaches as well. Therefore a biochemical assay was
used which correlates to cell proliferation. Figure 11c
shows that MSC colonised all scaffolds well and that
MSC numbers increased over the 24 to 72 h culture
period, which was particularly evident regarding the Ti-
containing scaffolds.
The greatest number of viable cells was supported by
Sc2 at 72 h. Previous work suggests stem cell seeded
scaffolds promote local cell function by the stem cell dif-
ferentiation and also enables the scaffold surface to mimic
complex local biological functions [31]. Stem cell coloni-
sation of the scaffolds presented here is a positive attribute
as it leads to the possibility of developing a stem cell
seeded scaffold for bone augmentation.
To conclude, a series of glass/ceramic scaffolds were
produced with TiO2 content increasing at the expense of
SiO2. The higher TiO2 containing scaffolds were found to
have a higher degree of crystallinity at the sintering tem-
perature which may be attributed to the higher hardness
value found. The higher TiO2 containing materials also had
a smaller mean pore diameter and higher level of porosity.
Bioactivity testing determined these materials to encourage
the growth of mesenchymal stem cells from 24 to 72 h,
which was particularly evident with the higher Ti-con-
taining scaffold, Sc2. This study suggests that Ti-substi-
tuted for Si may provide a beneficial structural and
therapeutic effect when fabricating glass/ceramic scaffolds
for bone augmentation. Future work on these materials will
include ion release studies and bioactivity testing using
SBF in order to determine if the scaffolds form any car-
bonate hydroxyapatite surface layer.
Fig. 9 X-ray microtomography imaging of a ScC, b Sc1 and c Sc2
Fig. 10 a Porosity and
b surface area of scaffolds
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